Lynch syndrome awareness day

Lynch syndrome. Even though it is the most common hereditary cancer syndrome in the world, it is mostly unknown. Lynch syndrome prevalence is currently estimated at 1 in 279 globally[1], meaning that in Europe alone

... read more

Announcement – CSO Appointment

We are excited to announce that Minttu Kansikas has been appointed as Chief Scientific Officer to lead the research efforts and laboratory functions. Congratulations! Minttu is a co-inventor and one of the leading scientists behind

... read more

Welcome to our updated Website

Welcome! We have updated our website and hope you enjoy the new structure and features! This new section being one of them, and the twitter feed, being another. And there are many more to come!

... read more

We are thrilled and proud to have been selected to the Bridgehead Global programme by EIT Health!

We are very much looking forward to explore opportunities and get ready for markets beyond Europe! #eithealth #bridgehead #diagmmr #lscancerdiag

📽️📺This week on StartUp Health TV watch chats w/ Health Transformers from StartUp Health companies @SandstoneDx, @AidarHealth, @welwaze, @conversahealth, @AshanaHealth, @lucidact/@xuemei19, #Rezilient, @Mediktor, @medisprout, @lscancerdiag


Lynch Syndrome is characterised by predisposition to colorectal, endometrial, ovarian and other cancers and is caused by inherited variants affecting the DNA mismatch repair genes. Probably the most common predisposition to cancer, (est. prevalence of between 1/100 and 1/180.)

Load More...